Participants 51 145 9
infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement:
Participants 186 273 3
anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study
Participants 321 440 8
inflammation and joint destruction in rheumatoid arthritis (RA) patients who have not responded clinically to treatment
Participants 2387 2425 3
patients without clinical improvement,
